Skip to content
2000
Volume 24, Issue 19
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Plants and crops contain a staggering diversity of compounds, many of which have pharmacological activity towards a variety of diseases. These properties have been exploited by traditional and modern medicine providing important sources of healthcare to this day. The contribution of natural products (such as plant-derived) to the modern pharmacopeia is indeed significant; however, the process of identifying novel bioactive compounds from biological sources has been a central challenge in the discovery of natural products. The resolution of these challenges relied extensively on the use of hyphenated Mass Spectrometry (MS) and Nuclear Magnetic Resonance (NMR)-based analytical technologies for the structural elucidation and annotation of novel compounds. Technical developments in instrumentation and data processing have fostered the development of the field of metabolomics which provides a wealth of tools with the huge potential for application in the process of drug/bioactive discovery from plant tissues. This manuscript provides an overview of the metabolomics toolbox available for the discovery of novel bioactive compounds and the integration of these tools in the bioprospection and drug discovery workflows.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612824666180515125926
2018-05-01
2025-04-21
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612824666180515125926
Loading

  • Article Type:
    Review Article
Keyword(s): bioactivity; bioprospection; chemical diversity; drug discovery; Metabolomics; plants
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test